Literature DB >> 6821501

Infections with non-penicillinase-producing Neisseria gonorrhoeae treated with cefuroxime: treatment failures.

D de Hoop, K C Nayyar, B van Klingeren, E Stolz, M F Michel.   

Abstract

Two men who acquired acute gonococcal urethritis in The Netherlands and who were treated with cefuroxime (1.5 g given intramuscularly) failed to respond to this therapy. Pre- and post-treatment isolates of Neisseria gonorrhoeae from these patients had MICs of 0.5 and 1.0 microgram of cefuroxime/ml.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6821501     DOI： 10.1097/00007435-198210000-00007

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  6 in total

1.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae: a trial organised as part of the United Kingdom national external quality assessment scheme for microbiology.

Authors:  J J Snell; D F Brown
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

Review 2.  [Resistance to antimicrobial agents. A WHO Scientific Working Group].

Authors: 
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

3.  In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.

Authors:  M Peeters; E Van Dyck; P Piot
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

Review 4.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin).

Authors:  R Schift; J van Ulsen; M C Ansink-Schipper; T van Joost; M F Michel; R K Woudstra; E Stolz
Journal:  Genitourin Med       Date:  1986-10

6.  Antimicrobial resistance.

Authors: 
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.